Clinical Trials on Essential Thrombocythemia (ET) in Japan
Total 52 results
-
ShireCompletedEssential Thrombocythemia (ET)Japan
-
ShireCompletedEssential Thrombocythemia (ET)Japan
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada
-
PharmaEssentiaMedpace, Inc.; EPS International; Brightech InternationalActive, not recruitingEssential ThrombocythemiaUnited States, Canada, Korea, Republic of, China, Hong Kong, Singapore, Taiwan, Japan
-
PfizerTerminatedPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia MyelofibrosisUnited States, Japan
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Merck Sharp & Dohme LLCRecruitingEssential ThrombocythemiaPoland, Israel, Australia, Hong Kong, Japan, New Zealand, Taiwan, Korea, Republic of, United States, Spain, Italy, Netherlands, Germany
-
Incyte CorporationRecruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, France, Italy, Japan, United Kingdom, Canada
-
CelgeneActive, not recruiting
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Novartis PharmaceuticalsCompleted
-
Kurume UniversityUnknownEfficacy of Olmesartan on Cerebral Glucose Metabolism in Essential HypertensionJapan
-
NovartisCompleted
-
NovartisCompleted
-
Novartis PharmaceuticalsCompletedEssential HypertensionJapan
-
Kyoto UniversityCompleted
-
Daiichi Sankyo Co., Ltd.CompletedEssential HypertensionJapan
-
NovartisCompleted
-
NovartisCompleted
-
Tokyo UniversityCompleted
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo, Inc.CompletedEssential HypertensionJapan
-
Daiichi Sankyo Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Completed
-
TakedaWithdrawnEssential Hypertension With Stable Angina and DyslipidemiaJapan
-
Kyowa Kirin Co., Ltd.CompletedPsoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic ErythrodermaJapan
-
BayerCompleted
-
TakedaCompletedEssential Hypertension Complicated by Type 2 Diabetes MellitusJapan
-
Kyoto UniversityUniversity of the RyukyusCompleted
-
Kyowa Kirin Co., Ltd.CompletedPsoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic ErythrodermaJapan
-
NovartisCompleted
-
TakedaCompletedGrade I or II Essential HypertensionJapan
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential HypertensionJapan
-
Novartis PharmaceuticalsCompletedEssential HypertensionJapan
-
InSightecTerminatedEssential TremorChina, Japan, Taiwan
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
InSightecCompletedEssential TremorCanada, United States, Japan, Korea, Republic of
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedHypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
Novartis PharmaceuticalsCompletedEssential HypertensionChina, Taiwan, Japan, Thailand, Korea, Republic of
-
Novartis PharmaceuticalsCompletedEssential HypertensionTaiwan, Japan, Philippines, China, Korea, Republic of, Malaysia
-
TakedaCompletedEssential HypertensionJapan